LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
(FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | |
---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||
Cash flow from continuing operating activities | 111.61%956.16M | -652.10%-8.23B | -683.16%-1.09B | 96.08%-139.77M | -126.54%-3.56B | -1.57B |
Net income from continuing operations | -13.53%-10.38B | -87.92%-9.14B | -78.01%-4.86B | 26.00%-2.73B | -163.91%-3.69B | ---1.4B |
Operating gains losses | -66.92%458.89M | 246.36%1.39B | 34.04%-947.84M | -4,023.38%-1.44B | 83.58%-34.85M | ---212.28M |
Depreciation and amortization | 49.38%2.11B | 68.38%1.41B | 91.30%837.8M | 93.21%437.94M | 137.02%226.67M | --95.63M |
Other non cash items | -48.19%-352.18M | 32.47%-237.66M | -435.85%-351.93M | 1.66%-65.68M | -19.50%-66.78M | ---55.89M |
Change In working capital | 371.34%7.35B | -175.60%-2.71B | 43.66%3.58B | 1,413.15%2.49B | -6,255.84%-189.98M | ---2.99M |
-Change in receivables | 84.96%-301.01M | 47.87%-2B | -293.78%-3.84B | -48.45%-975.18M | -953.64%-656.9M | ---62.35M |
-Change in inventory | 4.73%-2.36B | -27.60%-2.48B | -97.68%-1.94B | -148.93%-981.52M | -185.98%-394.3M | ---137.88M |
-Change in prepaid assets | 250.44%329.65M | 66.39%-219.13M | 17.76%-652.03M | -89.63%-792.86M | -50.59%-418.1M | ---277.65M |
-Change in payables and accrued expense | 358.77%9.02B | -79.39%1.97B | 95.06%9.55B | 288.28%4.89B | 151.24%1.26B | --501.63M |
-Change in other current assets | 752.76%150.94M | 66.06%-23.12M | -121.16%-68.14M | -448.58%-30.81M | 77.30%-5.62M | ---24.74M |
-Change in other current liabilities | 289.61%270.93M | -186.22%-142.89M | -131.44%-49.92M | 371.58%158.8M | -1,236.17%-58.47M | ---4.38M |
-Change in other working capital | 26.63%235.49M | -68.42%185.96M | 164.22%588.9M | 168.11%222.89M | 3,413.61%83.13M | --2.37M |
Cash from discontinued investing activities | ||||||
Operating cash flow | 111.61%956.16M | -652.10%-8.23B | -683.16%-1.09B | 96.08%-139.77M | -126.54%-3.56B | ---1.57B |
Investing cash flow | ||||||
Cash flow from continuing investing activities | -86.98%631.17M | 114.65%4.85B | -650.67%-33.08B | -695.19%-4.41B | 120.39%740.3M | -3.63B |
Net PPE purchase and sale | 50.27%-2.09B | -84.52%-4.2B | -191.16%-2.28B | 57.32%-781.56M | -137.88%-1.83B | ---769.85M |
Net intangibles purchase and sale | 46.75%-215.18M | 79.98%-404.06M | -262.79%-2.02B | -624.79%-556.35M | 67.89%-76.76M | ---239.06M |
Net business purchase and sale | --684.21M | --0 | --0 | ---- | --0 | --0 |
Net investment purchase and sale | -71.47%2.65B | 132.26%9.28B | -768.69%-28.77B | -224.27%-3.31B | 201.59%2.67B | ---2.62B |
Net other investing changes | -339.34%-397.93M | 1,733.52%166.26M | -104.17%-10.18M | 1,551.50%243.84M | -937.02%-16.8M | --2.01M |
Cash from discontinued investing activities | ||||||
Investing cash flow | -86.98%631.17M | 114.65%4.85B | -650.67%-33.08B | -695.19%-4.41B | 120.39%740.3M | ---3.63B |
Financing cash flow | ||||||
Cash flow from continuing financing activities | 33.50%8.02B | -58.95%6B | -57.39%14.63B | 855.31%34.33B | -46.64%3.59B | 6.73B |
Net issuance payments of debt | -50.12%3B | 295.84%6.01B | 530.96%1.52B | -140.38%-352.05M | -0.92%871.94M | --880M |
Net common stock issuance | --5.02B | --0 | -52.02%13.15B | --27.4B | --0 | --0 |
Net preferred stock issuance | ---- | ---- | ---- | 177.58%7.28B | -55.18%2.62B | --5.85B |
Net other financing activities | ---- | 95.04%-1.83M | ---36.92M | ---- | --98.01M | ---- |
Cash from discontinued financing activities | ||||||
Financing cash flow | 33.50%8.02B | -58.95%6B | -57.39%14.63B | 855.31%34.33B | -46.64%3.59B | --6.73B |
Net cash flow | ||||||
Beginning cash position | 26.46%14.71B | -63.11%11.63B | 1,210.00%31.54B | 47.58%2.41B | 1,316.92%1.63B | --115.15M |
Current changes in cash | 266.87%9.6B | 113.39%2.62B | -165.62%-19.54B | 3,762.55%29.78B | -49.64%771.09M | --1.53B |
Effect of exchange rate changes | -103.16%-14.58M | 227.10%461.74M | 44.12%-363.28M | -12,784.41%-650.08M | 134.67%5.13M | ---14.78M |
End cash Position | 65.16%24.3B | 26.46%14.71B | -63.11%11.63B | 1,210.00%31.54B | 47.58%2.41B | --1.63B |
Free cash flow | 89.50%-1.36B | -138.56%-12.91B | -260.32%-5.41B | 72.54%-1.5B | -111.89%-5.47B | ---2.58B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | -- | -- | -- |